Public Board of Directors papers 30 June 2022

5. Well-Led

5.1 - Finance (Executive Summary)

YTD Budget YTD Actual

Variance

£'000

£'000

£'000 542 (239) (149)

NHS Clinical - Block Contract Income

(54,161) (1,168)

(53,619) (1,407)

NHS Clinical Income

This report outlines the consolidated financial performance of The Christie NHS Foundation Trust and its wholly owned subsidiary The Christie Pharmacy Ltd.

Charitably funded capital donations

0 0

(149)

Donated CEF grant income Other non clinical income

0

0

(10,150) (65,479) 31,151 16,592 14,774 62,518 (2,961)

(9,441) (64,616) 28,834 17,020 14,985 60,839 (3,777)

709 863 428 211

Income

Pay

(2,317)

Drugs

I&E • The trust is reporting a month 2 position of £446k deficit compared to a £439k deficit plan within the latest plan submission of an annual control total deficit of £2.6m. • The month 2 EBITDA position is a surplus of £3,777k • The month 2 I&E deficit is £3,393k, prior to adjusting for donated depreciation, charitably funded capital donations, donated grant income, donated consumables, transfers by absorption and impairments. • 2022-23 CIP - £2.4m has been identified at this stage against a recurrent 22/23 CIP plan of £7.3m Balance sheet / liquidity • The cash balance is £147,055k. • Debtor days increased from 10 to 14 days from the previous month. • Capital expenditure is 44% below the NHSI plan reflecting the Paterson and VAT. Other • No profit from TCPC is realised at month 2 22-23 and is not expected until TCPC have generated their contractual agreed value, in line with previous

Other non pay

Total expenditure

(1,679)

EBITDA

(816)

Non operating income Non operating expenditure

(958) 7,481 3,562

(321) 7,491 3,393

638

9

(Surplus) / Deficit Exclude impairments

(169)

(2,333)

(2,333)

0

Exclude charitably funded capital donations Exclude donated CEF grant income

0 0 0 0 0

149

149

0

0

Exclude donated depreciation

(789)

(763)

26

Exclude consumables donated from DHSC

0 0 0

0 0 0 6

Exclude contributions to expenditure - inventory donated Exclude gains/(losses) from transfers by absorption Adjusted financial performance (surplus) / deficit

439

446

Exchequer Cash Balances 2022-23

£175,000

£150,000

£125,000

£100,000

Cash balances

£'000

£75,000

£50,000

years this is to be expected in quarter 3 of this year. • 30 day PSPP is at 98% for trade and 93% NHS.

£25,000

60

33